Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Jazz Pharmaceuticals plc’s stock clocked out at $108.24, up 1.11% from its previous closing price of $107.05. In other words, the price has increased by $1.11 from its previous closing price. On the day, 0.6 million shares were traded. JAZZ stock price reached its highest trading level at $109.43 during the session, while it also had its lowest trading level at $106.56.
Ratios:
To gain a deeper understanding of JAZZ’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.33. For the most recent quarter (mrq), Quick Ratio is recorded 2.97 and its Current Ratio is at 3.38. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on March 07, 2025, Upgraded its rating to Buy and sets its target price to $179 from $145 previously.
Wells Fargo Upgraded its Equal Weight to Overweight on February 13, 2025, whereas the target price for the stock was revised from $130 to $170.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when COZADD BRUCE C sold 500 shares for $110.00 per share. The transaction valued at 55,000 led to the insider holds 437,973 shares of the business.
COZADD BRUCE C sold 500 shares of JAZZ for $53,950 on Jun 02 ’25. The Chairman & CEO now owns 438,473 shares after completing the transaction at $107.90 per share. On Jun 02 ’25, another insider, COZADD BRUCE C, who serves as the Officer of the company, bought 1,000 shares for $108.95 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAZZ now has a Market Capitalization of 6549710336 and an Enterprise Value of 9519025152. As of this moment, Jazz’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.60, and their Forward P/E ratio for the next fiscal year is 5.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.61 while its Price-to-Book (P/B) ratio in mrq is 1.60. Its current Enterprise Value per Revenue stands at 2.342 whereas that against EBITDA is 6.838.
Stock Price History:
The Beta on a monthly basis for JAZZ is 0.33, which has changed by 0.008196712 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, JAZZ has reached a high of $148.06, while it has fallen to a 52-week low of $95.49. The 50-Day Moving Average of the stock is 0.30%, while the 200-Day Moving Average is calculated to be -8.46%.
Shares Statistics:
It appears that JAZZ traded 1.24M shares on average per day over the past three months and 641000 shares per day over the past ten days. A total of 61.62M shares are outstanding, with a floating share count of 57.66M. Insiders hold about 4.71% of the company’s shares, while institutions hold 99.32% stake in the company. Shares short for JAZZ as of 1748563200 were 5714162 with a Short Ratio of 4.61, compared to 1745971200 on 5347695. Therefore, it implies a Short% of Shares Outstanding of 5714162 and a Short% of Float of 10.92.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
